Editas Medicine SG&A Expense (TTM) Trends

Editas Medicine Inc (EDIT)

3.38 +0.18 (+5.62%) USD | NASDAQ | Oct 04, 16:00

3.39 +0.01 (+0.30%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
June 30, 2024	66.99M
March 31, 2024	65.98M
December 31, 2023	69.65M
September 30, 2023	73.18M
June 30, 2023	74.43M
March 31, 2023	74.16M
December 31, 2022	70.70M
September 30, 2022	69.24M
June 30, 2022	69.19M
March 31, 2022	74.28M
December 31, 2021	76.18M
September 30, 2021	75.44M
June 30, 2021	79.20M
March 31, 2021	71.25M
December 31, 2020	67.57M
September 30, 2020	68.70M
June 30, 2020	64.50M
March 31, 2020	64.83M

Date	Value
December 31, 2019	64.55M
September 30, 2019	60.82M
June 30, 2019	58.42M
March 31, 2019	58.31M
December 31, 2018	55.01M
September 30, 2018	55.52M
June 30, 2018	54.82M
March 31, 2018	52.40M
December 31, 2017	50.50M
September 30, 2017	49.86M
June 30, 2017	48.52M
March 31, 2017	48.79M
December 31, 2016	46.26M
September 30, 2016	40.55M
June 30, 2016	33.46M
March 31, 2016	24.58M
December 31, 2015	18.10M
September 30, 2015	13.55M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

64.50M

Minimum

Jun 2020

79.20M

Maximum

Jun 2021

70.53M

Average

69.65M

Median

Dec 2023

SG&A Expense (TTM) Benchmarks